Todd Brown, MD, PhD | Johns Hopkins University Baltimore-India Clinical Trials Unit

Todd Brown, MD, PhD

CRS:

Role:

Position:

Co-investigator

Email:

Tbrown27@jhmi.edu

Committees

Member, Bone Complications Working Group of the Inflammation TSG (Aug 2008 – Present)
Member, Immune Activation Focus Group of Inflammation TSG (Aug 2014-Present)
Protocol Co-Chair, ACTG 5260s, ACTG 5318 (LEACH)
Protocol Vice-Chair, ACTG 5280, ACTG 5303
Co-chair, ACTG 5361s
Co-investigator, ACTG 5257

Leadership Committees

BWI CTU Leadership Committee

CRS

Roles

A5274: REMEMBER, Reducing Early Mortality and Early...

This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...

Read More

P1070, Dose-Finding and Pharmacogenetic Study of Efavirenz...

Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...

Read More

A5273: Multicenter Study of Options for Second-Line...

The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...

Read More

P1077FF: Formula Feeding Version of the PROMISE Study...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment...

A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...

Read More